<table border="0" cellpadding="0" cellspacing="0" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 10. Effect of Coadministered Drugs on Zidovudine AUC* 
</caption>
<tbody>
<tr>
<th colspan="6">Note: ROUTINE DOSE MODIFICATION OF ZIDOVUDINE IS NOT WARRANTED WITH COADMINISTRATION OF THE FOLLOWING DRUGS.</th>
</tr>
<tr>
<th colspan="1">Coadministered <br/>Drug and Dose</th>
<th colspan="1">Zidovudine<br/>Dose</th>
<th colspan="1">   n   </th>
<th colspan="2">Zidovudine <br/>Concentrations</th>
<th colspan="1">Concentration<br/>of Coadministered Drug</th>
</tr>
<tr>
<th colspan="1">AUC</th>
<th colspan="1">Variability</th>
</tr>
<tr>
<td> Atovaquone<br/> 750 mg q 12 hr with food<br/>
</td>
<td>200 mg q 8 hr<br/>
</td>
<td>14<br/>
</td>
<td>↑AUC<br/>31%<br/>
</td>
<td>Range<br/>23% to 78%<sup>†</sup>
<br/>
</td>
<td>↔<br/>
</td>
</tr>
<tr>
<td> Clarithromycin<br/> 500 mg twice daily<br/>
</td>
<td>100 mg q 4 hr<br/>x 7 days<br/>
</td>
<td>4<br/>
</td>
<td>↓AUC<br/>12%<br/>
</td>
<td>Range<br/>↓34% to ↑14%<br/>
</td>
<td>Not Reported<br/>
</td>
</tr>
<tr>
<td> Fluconazole <br/> 400 mg daily<br/>
</td>
<td>200 mg q 8 hr<br/>
</td>
<td>12<br/>
</td>
<td>↑AUC<br/>74%<br/>
</td>
<td>95% CI:<br/>54% to 98%<br/>
</td>
<td>Not Reported<br/>
</td>
</tr>
<tr>
<td> Lamivudine<br/> 300 mg q 12 hr<br/>
</td>
<td>single 200 mg<br/>
</td>
<td>12<br/>
</td>
<td>↑AUC<br/>13%<br/>
</td>
<td>90% CI:<br/>2% to 27%<br/>
</td>
<td>↔<br/>
</td>
</tr>
<tr>
<td> Methadone<br/> 30 to 90 mg daily<br/>
</td>
<td>200 mg q 4 hr<br/>
</td>
<td>9<br/>
</td>
<td>↑AUC<br/>43%<br/>
</td>
<td>Range<br/>16% to 64%<sup>†</sup>
<br/>
</td>
<td>↔<br/>
</td>
</tr>
<tr>
<td> Nelfinavir<br/> 750 mg q 8 hr  x 7 to 10 days<br/>
</td>
<td>single 200 mg<br/>
</td>
<td>11<br/>
</td>
<td>↓AUC<br/>35%<br/>
</td>
<td>Range<br/>28% to 41%<br/>
</td>
<td>↔<br/>
</td>
</tr>
<tr>
<td> Probenecid<br/> 500 mg q 6 hr x 2 days<br/>
</td>
<td>2 mg/kg q 8 hr<br/>x 3 days<br/>
</td>
<td>3<br/>
</td>
<td>↑AUC<br/>106%<br/>
</td>
<td>Range<br/>100% to 170%<sup>†</sup>
<br/>
</td>
<td>Not Assessed<br/>
</td>
</tr>
<tr>
<td> Rifampin 600 mg<br/> daily x 14 days<br/>
</td>
<td>200 mg q 8 hr<br/>x 14 days<br/>
</td>
<td>8<br/>
</td>
<td>↓AUC<br/>47%<br/>
</td>
<td>90% CI:<br/>41% to 53%<br/>
</td>
<td>Not Assessed<br/>
</td>
</tr>
<tr>
<td> Ritonavir<br/> 300 mg q 6 hr x 4 days<br/>
</td>
<td>200 mg q 8 hr<br/>x 4 days<br/>
</td>
<td>9<br/>
</td>
<td>↓AUC<br/>25%<br/>
</td>
<td>95% CI:<br/>15% to 34%<br/>
</td>
<td>↔<br/>
</td>
</tr>
<tr>
<td> Valproic acid<br/> 250 mg or 500 mg q 8 hr x 4 days<br/>
</td>
<td>100 mg q 8 hr<br/>x 4 days<br/>
</td>
<td>6<br/>
</td>
<td>↑AUC<br/>80%<br/>
</td>
<td>Range<br/>64% to 130%<sup>†</sup>
<br/>
</td>
<td>Not Assessed<br/>
</td>
</tr>
</tbody>
</table>